Donald Trump is pressing Health and Human Services Secretary Robert F. Kennedy Jr. to move more aggressively on reducing the U.S. childhood vaccination schedule, according to a Wall Street Journal report published July 28, 2026. At a meeting in May 2026 at Trump's northern Virginia golf course, the president asked Kennedy whether he had the "yips," a golf term for a sudden loss of fine motor control, to signal that his HHS secretary was not cutting enough vaccines from the recommended schedule. Trump hopes to make "alleviating autism" a component of his legacy, the Journal reported, and has taken issue with what he views as Kennedy's insufficiently aggressive changes to vaccination recommendations (The Guardian; WSJ).

The pressure arrives at a moment of institutional paralysis for Kennedy's vaccine agenda. In January 2026, Kennedy slashed the routine childhood immunization schedule from 17 vaccines to 11, a move formalized in an HHS decision memo dated January 5, 2026, that adopted a revised childhood and adolescent immunization schedule covering diseases including measles, mumps, rubella, diphtheria, tetanus, hepatitis B, rotavirus, meningococcal disease, influenza, and COVID-19 (HHS decision memo). Two months later, in March 2026, a federal judge ordered a halt to Kennedy's vaccine policy changes in response to a lawsuit from the American Academy of Pediatrics. The same ruling paused the work of ACIP, the Advisory Committee on Immunization Practices, a panel of experts that sets U.S. vaccine recommendations. The court found ACIP had been illegally formed under Kennedy. Kennedy has not made any significant changes to the vaccine schedule since that court order, though the government is appealing the stay (The Guardian).

The schedule overhaul was preceded by a series of structural moves. Kennedy had ousted all previous members of the ACIP and published a Wall Street Journal op-ed in June 2025 arguing that HHS was working to restore public trust in vaccines by reconstituting an advisory committee he said had failed to adequately scrutinize vaccine products given to babies and pregnant women (HHS). By October 2025, the CDC updated its adult and child immunization schedules, making COVID-19 vaccination an individual-based decision and designating chickenpox vaccination as a standalone recommendation for toddlers (HHS press release). Kennedy also dropped recommendations for COVID-19 vaccines for children and pregnant women (WSJ). A White House fact sheet published in December 2025 noted that when Trump returned to office in January 2025, the United States recommended vaccinating all children for 18 diseases, including COVID-19 (White House).

The political calculus around the vaccine cuts has been volatile. In December 2025, Trump pollster Tony Fabrizio circulated a memo finding that anti-vaccine moves are unpopular with voters in key districts and concluding that "skepticism toward vaccine requirements is politically risky for both parties" (The Guardian; Fabrizio Ward). Two days after that poll circulated, Trump issued a White House memo directing HHS to align U.S. childhood vaccine recommendations with "peer" developed nations (White House). Chief of Staff Susie Wiles subsequently gave HHS a deadline of New Year's Eve 2025 to implement vaccine changes so the issue would fall into the background ahead of the midterm elections, according to Rolling Stone (The Guardian). The White House has since put a hold on further vaccine changes after polling indicated they were a losing issue in the midterms (The Guardian).

The American Public Health Association issued a statement in January 2026 criticizing the administration's vaccine schedule changes as a "secretive process" that puts families at risk (APHA). Scientists, according to the Wall Street Journal, say there is no reason to pare down the childhood vaccine schedule (WSJ).

The broader context here is a collision between three forces: a president who has personalized the vaccine issue as a legacy item, an HHS secretary whose implementing authority has been curtailed by a federal court, and a political apparatus that has identified vaccine skepticism as an electoral liability. Trump's May 2026 confrontation with Kennedy suggests the court stay has not extinguished his appetite for further cuts. The hold the White House placed on vaccine policy after midterm polling registered public opposition creates a direct tension with the president's private pressure on Kennedy. Whether Kennedy can act on that pressure depends on the outcome of the government's appeal of the March 2026 injunction, which paused both his policy changes and the operation of the reconstituted ACIP. The appeal's timeline and prospects remain undisclosed.

What is notable is the gap between the administration's framing and the scientific consensus. The White House has justified schedule reductions by pointing to alignment with peer developed nations. Scientists cited by the Journal see no clinical basis for paring down the schedule. Kennedy's op-ed framing centered on restoring public trust through heightened scrutiny of vaccine products. The APHA criticized the process itself, not merely the outcomes, calling it "secretive." These are not disagreements on the margin; they go to the evidentiary foundation for the policy. The federal court's March 2026 ruling, which found ACIP was illegally constituted, has effectively frozen the mechanism Kennedy built to implement his vision, leaving the policy in a state of suspended animation even as the president demands more.